2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Hepatocellular
61
Stomach Neoplasms
46
Carcinoma, Non-Small-Cell Lung
37
Colorectal Neoplasms
24
Esophageal Squamous Cell Carcinoma
19
Lung Neoplasms
12
Rectal Neoplasms
11
Nasopharyngeal Carcinoma
11
Esophageal Neoplasms
11
Neoplasms
8
Squamous Cell Carcinoma of Head and Neck
7
Pancreatic Neoplasms
7
Neoplasm Metastasis
7
Cholangiocarcinoma
6
Uterine Cervical Neoplasms
5
Small Cell Lung Carcinoma
5
Liver Neoplasms
5
Triple Negative Breast Neoplasms
4
Recurrence
4
Endometrial Neoplasms
4
Colonic Neoplasms
4
Carcinoma, Renal Cell
4
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma, Extranodal NK-T-Cell
3
Colorectal Cancer Metastatic
3
Carcinoma
3
Breast Neoplasms
3
Advanced Solid Tumors
3
Advanced Solid Tumor
3
Turcot syndrome
2
Interventions
sintilimab
1
nedaplatin
1
Pemetrexed
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Advanced Non-squamous Non-Small-Cell Lung Cancer
×
sintilimab
×
Clear all
NCT05648071
2022-12-13
SPBPDC
Qianfoshan Hospital
Phase 3
Unknown
60 enrolled